PATENT CLAIM ANALYSIS

Application Number: 16081657
Application Type: Utility
Filing Date: 2018-08
Publication Date: 2019-03
Patent Classification: ["514", "226800"]

Abstract:
Compounds and compositions are provided as inhibitors of the Wnt/β-catenin pathway for the treatment of diseases that implicate the same.

Claim (Index 37):
The method of  claim 1 , wherein the disease is non-alcoholic steatohepatitis (NASH).

Metadata:
- Claim Count in Document: 27.0
- Percentile: 96.0
- Lexical Diversity: 1.16667
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['14774597', '15567668', '12899410', '15204804', '14759542']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7809589390576649
- 35 USC 102 Novelty (BERT): 0.5298188568329365
- Combined Prediction Score: 0.7558449308351921
- Mean Citation Score: 320.0911700000001
- Max Citation Score: 340.64755
- Similarity Product: 216.60903296217623

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test